tiprankstipranks
Trending News
More News >

MannKind to present results from study of inhaled Technosphere Insulin

MannKind announced that it will present an oral presentation describing meal challenge results at the 16th International Conference on Advanced Technologies & Treatment for Diabetes in Berlin February 22-25. Dr. Kevin Kaiserman, Vice President, Medical Affairs, Endocrine Business Unit for MannKind, will report meal challenge results from the Afrezza with Basal Combination proof-of-concept study during an oral presentation delivered on Feb 25. The data showed that subjects utilizing inhaled Technosphere Insulin lowered peak glucose levels 30 minutes faster (200 mg/dl at 60 minutes) than subjects utilizing a rapid-acting analogue with an Automated Insulin Delivery system (264 mg/dl at 90 minutes). Subjects utilizing TI also experienced a significantly lower mean PPG from 45 to 120 minutes post-meal.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on MNKD:

Disclaimer & DisclosureReport an Issue